A rare fibroproliferative disorder
The identification of a novel disorder: the VEXAS syndrome
ANA titers may by more dynamic than previously accepted
Puzzling constellation of findings lead to CT-guided bone biopsy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Co-management increases opportunities for research and education
Study finds patients with asthma are at higher risk for developing SLE
Anti-IL-6 and anti-IL-1 agents: Center stage for COVID-19 stage 3 disease
The search for new therapeutic targets
Advertisement
Advertisement